Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cephalon
Pharma
Teva's Cephalon to pay $65.8M in Provigil pay-for-delay suit
Mired in pay-for-delay suits over narcolepsy drug Provigil, Teva’s Cephalon is looking to clear the field. A $65.8 million settlement could help.
Kyle Blankenship
Aug 12, 2019 11:16am
Mylan signs off on $96.5M pay-for-delay settlement
Feb 7, 2017 9:31am
Teva's Cephalon forks over $125M in second pay-for-delay settlement
Aug 9, 2016 5:07pm